Science Isn't Really Willing To Investigate Misconduct

Seven years ago, Jerome Jacobstein, a nuclear physician at Cornell University began to suspect what he thought was serious research misconduct on the part of colleague Jeffrey S. Borer. Borer, a cardiologist, was working with Jacobstein on studies of how the heart functions under stress. While reading a draft of a report on their work by a medical student under Borer’s direct supervision, Jacobstein discovered that much of the methodology was, he thought, inaccurately described, with the

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Seven years ago, Jerome Jacobstein, a nuclear physician at Cornell University began to suspect what he thought was serious research misconduct on the part of colleague Jeffrey S. Borer. Borer, a cardiologist, was working with Jacobstein on studies of how the heart functions under stress. While reading a draft of a report on their work by a medical student under Borer’s direct supervision, Jacobstein discovered that much of the methodology was, he thought, inaccurately described, with the inaccuracies tending to make the research appear to be more rigorous than it actually was. After hearing from the student that the inaccuracies had come from Borer, Jacobstein objected to the report, which was published without his name in the American Journal of Cardiology (51:1091-1097, 1983). Jacobstein also presented his evidence to Cornell authorities, who dismissed the charges after a brief inquiry lie then took the matter to NIH, where investigators deliberated for ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies